T2 Biosystems, Inc.
TTOODelisted Jul 10, 2025- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001492674
T2 Biosystems, Inc. was delisted on Jul 10, 2025; its insiders filed their last Form 4 on Jan 2, 2025; 1 institution reported holding it in 13F filings for Q2 2025, worth $0 in total; no superinvestor held it.
Q2 2024 vs. Q1 2024
How the institutions holding T2 Biosystems, Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 19 | 21 | +2 |
| Shares | 173.3K | 2.35M | +2.18M (+1,256.6%) |
| Value | $519.8K | $12.6M | +$12.0M (+2,315.1%) |
New holders (6)
Institutions that held T2 Biosystems, Inc. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Armistice Capital, LLC | 1,658,000 | $8.85M | 0.23% |
| State Street Corp | 63,743 | $340.4K | 0.00% |
| Northern Trust Corp | 38,879 | $207.6K | 0.00% |
| Goldman Sachs Group Inc | 14,705 | $78.5K | 0.00% |
| International Assets Investment Management, LLC | 33 | $176 | 0.00% |
| JPMorgan Chase & Co | 15 | $80 | 0.00% |
Sold out (4)
Institutions that held T2 Biosystems, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Virtu Financial LLC | 13,096 | $39.0K |
| Signature Resources Capital Management, LLC | 90 | $565 |
| Wells Fargo & Company | 27 | $81 |
| Newbridge Financial Services Group, Inc. | 10 | $30 |